Best Practice & Research Clinical Endocrinology & Metabolism
Volume 24, Issue 2 , Pages 279-289 , April 2010

Genital anomalies in boys and the environment

  • Katharina M. Main, MD, PhD (Clinical Associate Research Professor)

      Affiliations

    • University Department of Growth and Reproduction GR, Section 5064, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +45 35455085; fax: +45 35456054.
    • ,
  • Niels E. Skakkebæk, MD, DMSc (Professor)

      Affiliations

    • University Department of Growth and Reproduction GR, Section 5064, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
    • Tel.: +45 35455085, Fax: +45 35456054.
    • ,
  • Helena E. Virtanen, MD, PhD (Senior Researcher)

      Affiliations

    • Departments of Physiology and Pediatrics, University of Turku and Turku University Hospital, Kiinnamyllynkatu 10, FI-20520 Turku, Finland
    • Tel: +35 82 2502610 Fax: +35 82 3337297.
    • ,
  • Jorma Toppari, MD, PhD (Professor)

      Affiliations

    • Departments of Physiology and Pediatrics, University of Turku and Turku University Hospital, Kiinnamyllynkatu 10, FI-20520 Turku, Finland
    • Tel: +35 82 2502610 Fax: +35 82 3337297.

References 

  1. Jacobsen R, Møller H, SØ Thoresen, et al. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. International Journal of Andrology. 2006;29:199–204
  2. Carlsen E, Giwercman A, Skakkebæk NE, et al. Decreasing quality of semen. British Medical Journal. 1993;306:461
  3. Swan SH, Elkin EP, Fenster L. Have sperm densities declined? A re-analysis of global trend data. Environmental Health Perspectives. 1997;105:1228–1232
  4. Jensen TK, Sobotka T, Hansen MA, et al. Declining trends in conception rates in recent birth cohorts of native Danish women: a possible role of deteriorating male reproductive health. International Journal of Andrology. 2008;31:81–92
  5. Travison TG, Araujo AB, O'Donnell AB, et al. A population-level decline in serum testosterone levels in American men. The Journal of Clinical Endocrinology and Metabolism. 2007;92:196–202
  6. Andersson AM, Jensen TK, Juul A, et al. Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. The Journal of Clinical Endocrinology and Metabolism. 2007;92:4696–4705
  7. Skakkebæk NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction. 2001;16:972–978
  8. Welsh M, Saunders PT, Fisken M, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. The Journal of Clinical Investigation. 2008;118:1479–1490
  9. Toppari J, Larsen JC, Christiansen P, et al. Male reproductive health and environmental xenoestrogens. Environmental Health Perspectives. 1996;104:741–803
  10. Skakkebæk NE, Rajpert-De Meyts E, Jørgensen N, et al. Testicular cancer trends as "whistle blowers" of testicular developmental problems in populations. International Journal of Andrology. 2007;30:198–205
  11. Toppari J, Kaleva M, Virtanen HE. Trends in the incidence of cryptorchidism and hypospadias, and methodological limitations of registry-based data. Human Reproduction Update. 2001;7:282–286
  12. Boisen KA, Kaleva M, Main KM, et al. Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet. 2004;363:1264–1269
  13. John Radcliffe Hospital Cryptorchidism Study Group . Cryptorchidism: a prospective study of 7500 consecutive male births, 1984–8. Archives of Disease in Childhood. 1992;67:892–899
  14. Pierik FH, Burdorf A, de Muinck Keizer-Schrama SM, et al. The cryptorchidism prevalence among infants in the general population of Rotterdam, the Netherlands. International Journal of Andrology. 2005;28:248–252
  15. Berkowitz GS, Lapinski RH, Dolgin SE, et al. Prevalence and natural history of cryptorchidism. Pediatrics. 1993;92:44–49
  16. Thong M, Lim C, Fatimah H. Undescended testes: incidence in 1,002 consecutive male infants and outcome at 1 year of age. Pediatric Surgery International. 1998;13:37–41
  17. Preiksa RT, Zilaitiene B, Matulevicius V, et al. Higher than expected prevalence of congenital cryptorchidism in Lithuania: a study of 1204 boys at birth and 1 year follow-up. Human Reproduction. 2005;20:1928–1932
  18. Scorer CG. The descent of the testis. Archives of Disease in Childhood. 1964;39:605–609
  19. Cortes D, Kjellberg EM, Breddam M, et al. The true incidence of cryptorchidism in Denmark. The Journal of Urology. 2008;179:314–318
  20. Boisen KA, Chellakooty M, Schmidt IM, et al. Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at 3 months of age. The Journal of Clinical Endocrinology and Metabolism. 2005;90:4041–4046
  21. Virtanen HE, Kaleva M, Haavisto A-M, et al. The birth rate of hypospadias in the Turku area in Finland. APMIS. 2001;109:96–100
  22. Main KM, Toppari J, Suomi A-M, et al. Larger Testes and higher inhibin B levels in Finnish than in Danish newborn boys. The Journal of Clinical Endocrinology and Metabolism. 2006;91:2732–2737
  23. Jørgensen N, Carlsen E, Nermoen I, et al. East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Human Reproduction. 2002;17:2199–2208
  24. Pierik FH, Burdorf A, Nijman JM, et al. A high hypospadias rate in the Netherlands. Human Reproduction. 2002;17:1112–1115
  25. Dolk H, Vrijheid M, Scott JE, et al. Toward the effective surveillance of hypospadias. Environmental Health Perspectives. 2004;112:398–402
  26. Kallen B, Bertollini R, Castilla E, et al. A joint international study on the epidemiology of hypospadias. Acta Paediatrica Scandinavica. Supplement. 1986;324:1–52
  27. Paulozzi LJ. International trends in rates of hypospadias and cryptorchidism. Environmental Health Perspectives. 1999;107:297–302
  28. Nassar N, Bower C, Barker A. Increasing prevalence of hypospadias in Western Australia, 1980-2000. Archives of Disease in Childhood. 2007;92:580–584
  29. Gricius K, Valentinas J, Malcius D, et al. Birth incidence of subsequently operated hypospadias in Lithuania during 1966–1990. Acta Medica Lithuania. 1996;2:91–93
  30. Porter MP, Faizan MK, Grady RW, et al. Hypospadias in Washington State: maternal risk factors and prevalence trends. Pediatrics. 2005;115:e495–e499
  31. Aho M, Koivisto AM, Tammela TL, et al. Is the incidence of hypospadias increasing? Analysis of Finnish hospital discharge data 1970–1994. Environmental Health Perspectives. 2000;108:463–465
  32. Carmichael SL, Shaw GM, Nelson V, et al. Hypospadias in California: trends and descriptive epidemiology. Epidemiology. 2003;14:701–706
  33. Fisch H, Lambert SM, Hensle TW, et al. Hypospadias rates in New York state are not increasing. The Journal of Urology. 2009;181:2291–2294
  34. Lund L, Engebjerg MC, Pedersen L, et al. Prevalence of Hypospadias in Danish Boys: A Longitudinal Study, 1977–2005. European Urology. 2009;Epub ahead of print
  35. Toledano MB, Hansell AL, Jarup L, et al. Temporal trends in orchidopexy, Great Britain, 1992–1998. Environmental Health Perspectives. 2003;111:129–132
  36. Abdullah NA, Pearce MS, Parker L, et al. Birth prevalence of cryptorchidism and hypospadias in Northern England, 1993–2000. Archives of Disease in Childhood. 2007;92:576–579
  37. Richiardi L, Vizzini L, Nordenskjold A, et al. Rates of orchiopexies in Sweden: 1977–1991. International Journal of Andrology. 2008;Epub ahead of print
  38. Chilvers C, Pike MC, Forman D, et al. Apparent doubling of frequency of undescended testis in England and Wales in 1962–81. Lancet. 1984;ii:330–332
  39. Suomi A-M, Main KM, Kaleva M, et al. Hormonal changes in 3-month-old cryptorchid boys. The Journal of Clinical Endocrinology and Metabolism. 2006;91:953–958
  40. Kalfa N, Philibert P, Sultan C. Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation?. International Journal of Andrology. 2009;32:187–197
  41. Virtanen HE, Bjerknes R, Cortes D, et al. Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatrica. 2007;96:611–616
  42. Crain DA, Janssen SJ, Edwards TM, et al. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertility and Sterility. 2008;90:911–940
  43. Garcia-Rodriguez J, Garcia-Martin M, Nogueras-Ocana M, et al. Exposure to pesticides and cryptorchidism: geographical evidence of a possible association. Environmental Health Perspectives. 1996;104:1090–1095
  44. Pierik FH, Burdorf A, Deddens JA, et al. Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys. Environmental Health Perspectives. 2004;112:1570–1576
  45. Weidner IS, Møller H, Jensen TK, et al. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environmental Health Perspectives. 1998;106:793–796
  46. Fernandez MF, Olmos B, Granada A, et al. Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: a nested case-control study. Environmental Health Perspectives. 2007;115(Suppl 1):8–14
  47. Vrijheid M, Armstrong B, Dolk H, et al. Risk of hypospadias in relation to maternal occupational exposure to potential endocrine disrupting chemicals. Occupational and Environmental Medicine. 2003;60:543–550
  48. Araneta MR, Schlangen KM, Edmonds LD, et al. Prevalence of birth defects among infants of Gulf War veterans in Arkansas, Arizona, California, Georgia, Hawaii, and Iowa, 1989–1993. Birth Defects Research. Part A, Clinical and Molecular Teratology. 2003;67:246–260
  49. Tielemans E, van Kooij R, te Velde E, et al. Pesticide exposure and decreased fertilisation rates in vitro. Lancet. 1999;354:484–485
  50. de Cock J, Westveer K, Heederik D, et al. Time to pregnancy and occupational exposure to pesticides in fruit growers in The Netherlands. Occupational and Environmental Medicine. 1994;51:693–699
  51. Longnecker MP, Klebanoff MA, Brock JW, et al. Maternal serum level of 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene and risk of cryptorchidism, hypospadias, and polythelia among male offspring. American Journal of Epidemiology. 2002;155:313–322
  52. Bhatia R, Shiau R, Petreas M, et al. Organochlorine pesticides and male genital anomalies in the child health and development studies. Environmental Health Perspectives. 2005;113:220–224
  53. Brucker-Davis F, Wagner-Mahler K, Delattre I, et al. Cryptorchidism at birth in Nice area (France) is associated with higher prenatal exposure to PCBs and DDE, as assessed by colostrum concentrations. Human Reproduction. 2008;23:1708–1718
  54. Pierik FH, Klebanoff MA, Brock JW, et al. Maternal pregnancy serum level of heptachlor epoxide, hexachlorobenzene, and beta-hexachlorocyclohexane and risk of cryptorchidism in offspring. Environental Research. 2007;105:364–369
  55. Hosie S, Loff S, Witt K, et al. Is there a correlation between organochlorine compounds and undescended testes?. European Journal of Pediatric Surgery. 2000;10:304–309
  56. Hardell L, van Bavel B, Lindstrom G, et al. Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer. Environmental Health Perspectives. 2003;111:930–934
  57. McGlynn KA, Quraishi SM, Graubard BI, et al. Persistent organochlorine pesticides and risk of testicular germ cell tumors. Journal of the National Cancer Institute. 2008;100:663–671
  58. Damgaard IN, Skakkebæk NE, Toppari J, et al. Persistent pesticides in human breast milk and cryptorchidism. Environmental Health Perspectives. 2006;114:1133–1138
  59. Andersen HR, Schmidt IM, Grandjean P, et al. Impaired reproductive development in sons of women occupationally exposed to pesticides during pregnancy. Environmental Health Perspectives. 2008;116:566–572
  60. Main KM, Mortensen GK, Kaleva M, et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in three months old infants. Environmental Health Perspectives. 2006;114:270–276
  61. Liu X, Zhang DY, Li YS, et al. Di-(2-ethylhexyl) Phthalate upregulates ATF3 expression and suppresses apoptosis in mouse genital tubercle. Journal of Occupational Health. 2009;51:57–63
  62. Swan SH, Main KM, Liu F, et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environmental Health Perspectives. 2005;113:1056–1061
  63. Hsieh MH, Breyer BN, Eisenberg ML, et al. Associations among hypospadias, cryptorchidism, anogenital distance, and endocrine disruption. Current Urology Reports. 2008;9:137–142
  64. Duty SM, Calafat AM, Silva MJ, et al. The relationship between environmental exposure to phthalates and computer-aided sperm analysis motion parameters. Journal of Andrology. 2004;25:293–302
  65. Murature DA, Tang SY, Steinhardt G, et al. Phthalate esters and semen quality parameters. Biomedical & environmental mass spectrometry. 1987;14:473–477
  66. Duty SM, Calafat AM, Silva MJ, et al. Phthalate exposure and reproductive hormones in adult men. Human Reproduction. 2005;20:604–610
  67. Meeker JD, Calafat AM, Hauser R. Urinary Metabolites of di(2-ethylhexyl) phthalate are associated with decreased steroid hormone levels in adult men. Journal of Andrology. 2009;30:287–297
  68. Main KM, Kiviranta H, Virtanen HE, et al. Flame retardants in placenta and breast milk and cryptorchidism in newborn boys. Environmental Health Perspectives. 2007;115:1519–1526
  69. Stoker TE, Cooper RL, Lambright VS, et al. In vivo and in vitro anti-androgenic effects of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture. Toxicology and Applied Pharmacology. 2005;207:78–88
  70. Lilienthal H, Hack A, Roth-Härer A, et al. Effects of developmental exposure to 2,2'4,4',5-pentabromodiphenyl ether (PBDE-99) on sex steroids, sexual development, and sexually dimorphic behavior in rats. Environmental Health Perspectives. 2006;114:194–201
  71. Song R, He Y, Murphy MB, et al. Effects of fifteen PBDE metabolites, DE71, DE79 and TBBPA on steroidogenesis in the H295R cell line. Chemosphere. 2008;71:1888–1894
  72. Jensen AA, Leffers H. Emerging endocrine disrupters: perfluoroalkylated substances. International Journal of Andrology. 2008;31:161–169
  73. Fei C, McLaughlin JK, Lipworth L, et al. Maternal levels of perfluorinated chemicals and subfecundity. Human Reproduction. 2009;24:1200–1205
  74. Joensen UN, Boosi R, Leffers H, et al. Do perfluoroalkyl compounds impair human semen quality?. Environmental Health Perspectives. 2009;117:923–927
  75. Damgaard IN, Jensen TK, Petersen JH, et al. Risk factors for congenital cryptorchidism in a prospective birth cohort study. PLoS One. 2008;3:e3051
  76. Morales-Suarez-Varela MM, Bille C, Christensen K, et al. Smoking habits, nicotine use, and congenital malformations. Obstetrics and gynecology. 2006;107:51–57
  77. Biggs ML, Baer A, Critchlow CW. Maternal, delivery, and perinatal characteristics associated with cryptorchidism: a population-based case-control study among births in Washington State. Epidemiology. 2002;13:197–204
  78. Thorup J, Cortes D, Petersen BL. The incidence of bilateral cryptorchidism is increased and the fertility potential is reduced in sons born to mothers who have smoked during pregnancy. The Journal of Urology. 2006;176:734–737
  79. Jensen TK, Jørgensen N, Punab M, et al. Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. American Journal of Epidemiology. 2004;159:49–58
  80. Jensen MS, Mabeck LM, Toft G, et al. Lower sperm counts following prenatal tobacco exposure. Human Reproduction. 2005;20:2559–2566
  81. Storgaard L, Bonde JP, Ernst E, et al. Does smoking during pregnancy affect sonś sperm counts?. Epidemiology. 2003;14:278–286
  82. Fowler PA, Cassie S, Rhind SM, et al. Maternal smoking during pregnancy specifically reduces human fetal desert hedgehog gene expression during testis development. The Journal of Clinical Endocrinology and Metabolism. 2008;93:619–626
  83. Brokken LJ, Adamsson A, Paranko J, et al. Antiandrogen exposure in utero disrupts expression of desert hedgehog and insulin-like factor 3 in the developing fetal rat testis. Endocrinology. 2009;150:445–451
  84. Lackmann GM, Angerer J, Tollner U. Parental smoking and neonatal serum levels of polychlorinated biphenyls and hexachlorobenzene. Pediatric Research. 2000;47:598–601
  85. Mongraw-Chaffin ML, Cohn BA, Cohen RD, et al. Maternal smoking, alcohol consumption, and caffeine consumption during pregnancy in relation to a son's risk of persistent cryptorchidism: a prospective study in the Child Health and Development Studies cohort, 1959–1967. American Journal of Epidemiology. 2008;167:257–261
  86. Damgaard I, Jensen TK, Nordic Cryptorchidism Study Group The, et al. Cryptorchidism and maternal alcohol consumption during pregnancy. Environmental Health Perspectives. 2007;115:272–277
  87. Berkowitz GS, Lapinski RH. Risk factors for cryptorchidism: a nested case-control study. Paediatric and Perinatal Epidemiology. 1996;10:39–51
  88. Møller H, Skakkebæk NE. Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes & Control. 1997;8:904–912
  89. Henriksen TB, Hjollund NH, Jensen TK, et al. Alcohol consumption at the time of conception and spontaneous abortion. American Journal of Epidemiology. 2004;160:661–667
  90. Kortenkamp A. Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. International Journal of Andrology. 2008;31:233–240
  91. Christiansen S, Scholze M, Axelstad M, et al. Combined exposure to anti-androgens causes markedly increased frequencies of hypospadias in the rat. International Journal of Andrology. 2008;31:241–248
  92. Buck Louis GM, Gray LE, Marcus M, et al. Environmental factors and puberty timing: expert panel research needs. Pediatrics. 2008;3(121 Suppl):S192–S207
  93. Hotchkiss AK, Rider CV, Blystone CR, et al. Fifteen years after "Wingspread"–environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go. Toxicological Sciences. 2008;105:235–259
  94. Buemann B, Henriksen H, Villumsen ÅL, et al. Incidence of undescended testis in the newborn. Acta Chirurgica Scandinavica. 1961;(Suppl.283):289–293
  95. Virtanen HE, Tapanainen AE, Kaleva MM, et al. Mild gestational diabetes as a risk factor for congenital cryptorchidism. The Journal of Clinical Endocrinology and Metabolism. 2006;91:4862–4865

PII: S1521-690X(09)00140-7

doi: 10.1016/j.beem.2009.10.003

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 24, Issue 2 , Pages 279-289 , April 2010

Article Tools

* Image Usage & Resolution